Experimental and Clinical Contact Dermatitis Meetings

Information

  • Research Project
  • 6535808
  • ApplicationId
    6535808
  • Core Project Number
    R13AR049012
  • Full Project Number
    1R13AR049012-01
  • Serial Number
    49012
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/20/2002 - 22 years ago
  • Project End Date
    12/31/2002 - 22 years ago
  • Program Officer Name
    MASTIN, PATRICK
  • Budget Start Date
    9/20/2002 - 22 years ago
  • Budget End Date
    12/31/2002 - 22 years ago
  • Fiscal Year
    2002
  • Support Year
    1
  • Suffix
  • Award Notice Date
    5/13/2002 - 22 years ago

Experimental and Clinical Contact Dermatitis Meetings

DESCRIPTION (provided by applicant): This proposal requests support for the third meeting of the Experimental Contact Dermatitis Research Group (ECDRG). The ECDRG was founded in 1997 to provide a forum for North American scientists and physicians to discuss issues concerning irritant and allergic contact dermatitis. The first meeting was held in Cincinnati in May 1999 and the second in Dallas in Nov. 2000. The first two meetings have been useful in bringing together parties from academic medicine, university and research institute labs, industry, and government. This will be the second meeting held in conjunction with the American Contact Dermatitis Society (ACDS). The inclusion of the ACDS at the Dallas meeting brought together for the first time on a large scale a coalition of basic scientists and clinicians who have special expertise in contact dermatitis, which helped provide a translational research element in each segment of the meeting. This format was popular with the attendees and the meeting in Cleveland will follow the same combined format. In addition, a satellite meeting will be held on Skin Equivalents immediately prior to the ECDRG, which will help bring in scientists who use such technology to predict contact dermatitis, further enriching the meeting interactions. Three goals of the meeting are to provide an interdisciplinary forum: 1) To discuss: a) predictive methods that identify irritants and sensitizers before human exposure, b) methods to distinguish irritants from allergic responses with current tests, c) pathogenic mechanisms of dermatitis and possible interventions, d) factors that modify expression of dermatitis e) variables in sensitization that affect tolerance and disease expression, and translating these concepts into interventions that reduce or modify sensitization and elicitation and to induce tolerance. 2) To update attendees regarding: a) allergens that are newly recognized or increasingly recognized in clinical practice b) new technology as it applies to data analysis and epidemiology of dermatitis and c) opportunities arising from patient--centered interactions between clinicians, industry and government colleagues. 3) To enable participants to plan collaborative research projects and to introduce young scientists to the field. The proposed meeting will allow exchange not only among researchers in the various lab and clinical research settings, and clinicians but also between researchers interested in this field who see the practical outcomes in patients with diseases.

IC Name
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
  • Activity
    R13
  • Administering IC
    AR
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    15000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    113
  • Ed Inst. Type
  • Funding ICs
    NIAMS:12000\NIEHS:3000\
  • Funding Mechanism
  • Study Section
    AMS
  • Study Section Name
    Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee
  • Organization Name
    UNIVERSITY HOSPITALS OF CLEVELAND
  • Organization Department
  • Organization DUNS
    609373691
  • Organization City
    CLEVELAND
  • Organization State
    OH
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    441065000
  • Organization District
    UNITED STATES